COAGULATION FACTOR VIIA RECOMBINANT HUMAN

93 reported adverse events

These side effects are most commonly reported by patients taking COAGULATION FACTOR VIIA RECOMBINANT HUMAN:

# Side effect Count
0 DRUG INEFFECTIVE 26
1 OFF LABEL USE 20
2 HAEMORRHAGE 11
3 ANTI FACTOR VIII ANTIBODY POSITIVE 7
4 NO ADVERSE EVENT 7
5 COVID-19 4
6 FALL 4
7 HAEMARTHROSIS 4
8 HAEMATOMA 4
9 THERAPY NON-RESPONDER 4
See all common reactions for COAGULATION FACTOR VIIA RECOMBINANT HUMAN

COAGULATION FACTOR VIIA RECOMBINANT HUMAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FACTOR VIII ACTIVITY DECREASED 3 0.1304
1 FACTOR VII INHIBITION 1 0.0667
2 ANTI FACTOR IX ANTIBODY INCREASED 1 0.0556
3 ANTI FACTOR IX ANTIBODY POSITIVE 1 0.0435
4 PECTUS CARINATUM 1 0.0278
5 PLASMA CELLS DECREASED 1 0.0200
6 ANTI FACTOR VIII ANTIBODY INCREASED 2 0.0161
7 ANTI FACTOR VIII ANTIBODY POSITIVE 7 0.0124
8 TESTICULAR HAEMORRHAGE 1 0.0114
9 COMPLICATED APPENDICITIS 1 0.0085
See all enriched reactions for COAGULATION FACTOR VIIA RECOMBINANT HUMAN